A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
Clinical trial NCT06470048 · RECRUITING
Trial details
- NCT number
- NCT06470048
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-09
- Primary completion
- 2027-07-30
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.